How Much Does Ozempic Cost?

Updated on September 17, 2024 | Written by Alec Pow
This article was researched using 14 sources. See our methodology and corrections policy.

Ozempic can cost more than $1,000 per month at list or retail cash pricing, but current manufacturer programs can put eligible self-pay patients far below that level. Novo Nordisk lists the published Ozempic pen strengths and current tablet strengths at $1,027.51 each at list price, while its direct self-pay program lists the pen at $349 per month for the 0.25/0.5 mg and 1 mg pens and $499 per month for the 2 mg pen.

New eligible pen patients can pay $199 per month for their first two 0.25/0.5 mg fills through December 31, 2026. Insurance can produce a lower or higher out-of-pocket amount depending on the plan, deductible, formulary, indication, and authorization rules.

Article Highlights

• Ozempic’s current manufacturer list price is $1,027.51 (at $30 per hour, earning that amount would take about 4.3 full-time workdays, before taxes) for each marketed pen strength and current tablet strength.
• Standard self-pay pen pricing is $349 per month through 1 mg and $499 per month for 2 mg.
• New eligible pen patients can pay $199 per month for their first two 0.25/0.5 mg fills through December 31, 2026.
• Ozempic tablets have current self-pay prices of $149, $199, or $299 per month depending on strength.
• Eligible commercially insured patients may pay as little as $25 per month, subject to a $100 monthly maximum savings amount.
• The patient assistance route can provide Ozempic pen at $0 to qualifying applicants.

How Much Does Ozempic Cost?

The first number to separate is list price. Novo Nordisk’s current Ozempic list price is $1,027.51 (about 4.3 full-time workdays at $30 per hour) for the published 0.25/0.5 mg pen, 1 mg pen, 2 mg pen, and each of the three Ozempic tablet strengths. List price is a manufacturer benchmark before rebates or insurance adjustments. It is not a promise that a pharmacy will collect that exact amount.

Retail cash can be higher. A SingleCare price update from September 10, 2026 lists an estimated retail price of $1,394.89 for one 3 mL 0.25/0.5 mg multidose pen before discounts. The manufacturer self-pay route is much lower for eligible patients. NovoCare’s current self-pay terms list $349 for a 28-day pen through 1 mg, $499 for the 2 mg pen, and dose-based tablet prices starting at $149 per month.

Payment route	Current published amount	What the figure means
Manufacturer list price	$1,027.51	Same list price across current pen and tablet strengths
Retail cash example	$1,394.89	SingleCare estimate for one 3 mL 0.25/0.5 mg multidose pen
NovoCare pen self-pay	$349 to $499 per month	Lower strengths through 1 mg are $349, 2 mg is $499
NovoCare tablet self-pay	$149 to $299 per month	Price changes with 1.5 mg, 4 mg, or 9 mg strength

What Ozempic Is Approved to Treat

Ozempic is a prescription semaglutide medicine, and the form matters. The current FDA injection labeling covers adults with type 2 diabetes for glycemic control, reduction of major cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease, and reduction of certain kidney and cardiovascular risks in adults with type 2 diabetes and chronic kidney disease. The injection is given once weekly and can be prescribed in 0.25 mg, 0.5 mg, 1 mg, or 2 mg dosing steps under the label.

Ozempic now also has an oral formulation. The FDA tablet labeling lists 1.5 mg, 4 mg, and 9 mg tablets taken once daily for adults with type 2 diabetes, including a cardiovascular-risk indication for qualifying adults. The tablet and injection are not interchangeable milligram for milligram. The current FDA labels do not list chronic weight management as an Ozempic indication.

The May 2026 injection label also lists single-dose prefilled syringes at 0.25 mg, 0.5 mg, and 1 mg. The manufacturer price pages publish pen and tablet figures. The self-pay figures in this cost analysis apply to pens, not an assumed syringe price.

Price comparisons need the same form, strength, approved use, and supply period. Ozempic should not be treated as a generic weight-loss purchase or as interchangeable with every semaglutide product.

Injection Prices by Dose

The injection has two different dose-price stories. At list price, all three marketed pen strengths are $1,027.51 (about 4.3 full-time workdays at $30 per hour). Under the current NovoCare self-pay program cited above, the 0.25/0.5 mg pen and 1 mg pen are $349 per 28-day fill, while the 2 mg pen is $499. The manufacturer’s list price does not rise with injection strength, but the self-pay offer does at 2 mg.

The 2 mg self-pay tier adds $150 per fill compared with the $349 tier. If two otherwise comparable patients each had 12 eligible self-pay fills at those two price levels, the annual difference would be $1,800. That is a pricing calculation, not a treatment assumption. Dose selection is a clinical decision, and many patients will not spend a full year at one strength.

The old idea that a 0.25 mg pen costs about $250, a 0.5 mg pen about $590, and a 1 mg pen about $850 does not match current official pen pricing. FDA labeling now includes both single-patient-use multidose pens and certain single-dose prefilled syringes. The published self-pay figures apply to pens, not an assumed syringe price.

Ozempic Pill Prices

The oral version creates a second cost path. Current self-pay pricing established above is $149 per month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg. The FDA dosing schedule starts at 1.5 mg once daily for the first 30 days, moves to 4 mg for days 31 through 60, and can remain at 4 mg or increase to 9 mg after that depending on clinical need.

A 12-fill cost model shows why the maintenance strength matters. If an eligible self-pay patient has one 1.5 mg fill at $149 and then 11 fills at 4 mg for $199 each, the 12-fill total is $2,338. If the same model uses 9 mg from the third fill onward, the total becomes $3,338. The difference is $1,000 across the final 10 fills.

The oral option is new enough that older Ozempic cost pages may still describe the brand as injection-only. The current tablet price path is dose-based, while the pen self-pay path groups several lower pen strengths at one price and moves the 2 mg pen to a higher tier. Form and dosing should be matched before comparing pill and pen costs.

Insurance and Savings Cards

Commercial insurance can reduce Ozempic spending, but the plan decides whether the prescription is covered and what cost-sharing applies. The current Ozempic savings program says eligible commercially insured patients with coverage can pay as little as $25 per month, with maximum savings of $100 per month for up to 48 months. Government program beneficiaries are excluded from that commercial savings card.

The $25 figure is not a universal copay ceiling. If an eligible insurance claim left $200 for the patient and the card could apply its full $100 monthly maximum, the remaining amount would still be $100. A plan with a lower copay can reach the advertised minimum more easily. The exact result depends on card terms and the adjudicated insurance claim.

Coverage can depend on prior authorization and formulary rules. NovoCare’s coverage guidance says authorization may last from 30 days to more than a year. An expired authorization can change the payable amount without a prescription change.

Self-pay can lower the pharmacy charge but change annual insurance math. Manufacturer terms say an outside-insurance self-pay fill cannot be submitted for reimbursement or counted toward the deductible or out-of-pocket limit.

Medicare and Medicaid

Medicare and Medicaid need to be separated from the commercial savings card. Novo Nordisk states that Medicare Part D cost varies by plan and that Medicaid cost varies by state. People using these government programs cannot use the commercial $25 savings card. Some beneficiaries can still choose a manufacturer self-pay route, but a self-pay purchase made outside insurance does not count toward the plan deductible or out-of-pocket limit.

Medicare’s 2026 GLP-1 Bridge should not be mistaken for a blanket $50 Ozempic program. The current Medicare Bridge page lists selected weight-management drugs at $50 per month, including Wegovy and Zepbound, but it does not list Ozempic. Ozempic prescribed for an FDA-approved diabetes indication remains a Part D coverage question tied to the beneficiary’s plan.

Another change arrives in 2027. CMS has published a Medicare negotiated package price of $276.78 for one 4 mg/3 mL Ozempic pen beginning January 1, 2027. That is a maximum fair price used in the Medicare negotiation program, not a guaranteed patient copay.

For 2026 budgeting, the practical Medicare number still comes from the beneficiary’s Part D plan, not the future negotiated package price. The plan’s formulary, deductible stage, pharmacy network, and authorization rules can move the amount collected at each refill.

Patient Assistance

Novo Nordisk’s patient assistance route is different from both insurance and the commercial savings card. The current NovoCare Patient Assistance Program provides medicine at $0 to people who qualify, with no registration or monthly program fee. For uninsured Ozempic applicants in 2026, the page lists a household-income limit at or below 200% of the federal poverty level. Eligibility rules can change and require documentation.

The self-pay program has another tradeoff. It is a cash route rather than insurance. That can make the prescription cheaper at the pharmacy, but the payment is outside the health plan and may not help satisfy a deductible or annual out-of-pocket maximum. A patient comparing a $349 self-pay fill with a higher insurance claim should compare the immediate cash saving with the value of insurance accumulation over the rest of the year.

There is no reason to assume a cheap generic Ozempic exists. FDA published draft semaglutide generic guidance in July 2026 to support future generic development. Draft product guidance is not an approval of a generic Ozempic product. A pharmacy quote should identify the actual FDA-approved product being dispensed.

A Year of Ozempic

For a new eligible pen patient who receives two introductory 0.25/0.5 mg fills at $199 and then stays in the $349 self-pay tier for 10 fills, the 12-fill total is $199 + $199 + $3,490 = $3,888. Twelve fills at $349 would total $4,188, so the introductory offer saves $300 in this model. A move to the $499 2 mg tier would raise the total.

List-price arithmetic gives a very different figure. Twelve fills at $1,027.51 equal $12,330.12, but that number is a manufacturer benchmark rather than a prediction of what an insured or self-pay patient will hand to the pharmacy. Retail cash can also differ by pharmacy. Comparing annual totals only works when the form, strength, eligibility, and payment channel match.

For adjacent price research, compare Rybelsus costs, Wegovy costs, and Mounjaro out-of-pocket costs. They are separate products or brands, not interchangeable price substitutes.

Makes sense if

• You compare the insurance claim with the current manufacturer self-pay price before filling.
• You qualify for a commercial savings card and know the $100 monthly savings limit.
• You check patient-assistance eligibility before assuming list price is unavoidable.

Does not make sense if

• You treat the $25 savings-card headline as a guaranteed copay.
• You expect a cash self-pay purchase to count toward an insurance deductible.
• You compare Ozempic with a weight-management drug solely because both contain semaglutide.

Answers to Common Questions

How much does Ozempic cost without insurance?

Eligible self-pay patients can currently pay $349 per month for the 0.25/0.5 mg or 1 mg pen and $499 per month for the 2 mg pen. Retail cash prices outside the manufacturer program can be much higher.

How can I get Ozempic for $25?

The $25 offer is for eligible commercially insured patients with Ozempic coverage. It has a $100 per month maximum savings limit, so not every covered prescription will fall to $25.

Is there an Ozempic pill?

Yes. Ozempic tablets are now FDA-approved in 1.5 mg, 4 mg, and 9 mg strengths. Current eligible self-pay pricing is $149, $199, and $299 per month, respectively.

Is there a generic Ozempic?

FDA has published draft guidance intended to support future generic semaglutide development, but that is not the same as an approved generic Ozempic product.

Does Medicare make Ozempic $50 per month?

No. The 2026 Medicare GLP-1 Bridge’s $50 monthly price applies to selected weight-management drugs and does not list Ozempic. Ozempic costs under Medicare depend on Part D coverage and the specific plan.